Marco Cerrano

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Venues

Cancers

Leukemia

Blood advances

British journal of haematology

Azienda Ospedaliera Citta' Della Salute E Della Scienza Di Torino

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliera Citta' Della Salute E Della Scienza Di Torino

Italy

MD :: Dipartimento di Oncologia ed Ematologia

Publications

Elena Crisà, Elvira Mora, Ulrich Germing, Cecile Bally, Maria Diez Campelo, Mikko Myllymäki, Martin Jädersten, Rami S Komrokji, Uwe Platzbecker, Detlef Haase, Wolf-Karsten Hofmann, Najla H Al Ali, Daniela Barraco, Juan José Bargay, Teresa Bernal, Felix López Cadenas, Anna Calvisi, Isabella Capodanno, Marco Cerrano, Rosanna Ciancia, Monica Crugnola, Andrea Kündgen, Carlo Finelli, Claudio Fozza, Chiara Frairia, Ebeling Freja, Christina Ganster, Anne-Sophie Kubasch, Maria Jose Jimenez, Roberto Latagliata, Francisca Hernandez Mohedo, Antonieta Molero, Miriam Vara Pampliega, Clara Aparicio Perez, Giuseppe Pietrantuono, Antonella Poloni, Helena Pomares, Valle Recasens, Axel Rüfer, Alessio Signori, Eva Hellström Lindberg, Pierre Fenaux, Guillermo F Sanz, Valeria Santini
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study. Leukemia (2024)
Irene Urbino, Etienne Lengliné, Florence Rabian, Marco Cerrano, Rathana Kim, Florian Chevillon, Dario Ferrero, Marie Sébert, Nathalie Dhedin, Raphaël A Itzykson, Lionel Ades, Emmanuel Raffoux, Hervé Dombret, Ernesta Audisio, Emmanuelle Clappier, Nicolas Boissel
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. Blood advances 8 (10) (2024)
Irene Urbino, Etienne Lengliné, Florence Rabian, Marco Cerrano, Rathana Kim, Florian Chevillon, Dario Ferrero, Marie Sébert, Nathalie Dhedin, Raphaël A Itzykson, Lionel Ades, Emmanuel Raffoux, Hervé Dombret, Ernesta Audisio, Emmanuelle Clappier, Nicolas Boissel
Blinatumomab Consolidation for Adult B-Cell Acute Lymphoblastic Leukemia in First and Second Complete Remission. Blood advances (2024)
Irene Urbino, Etienne Lengliné, Florence Rabian, Marco Cerrano, Rathana Kim, Florian Chevillon, Dario Ferrero, Marie Sébert, Nathalie Dhedin, Raphaël A Itzykson, Lionel Ades, Emmanuel Raffoux, Hervé Dombret, Ernesta Audisio, Emmanuelle Clappier, Nicolas Boissel
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. Blood advances 8 (10) (2024)
Irene Urbino, Etienne Lengliné, Florence Rabian, Marco Cerrano, Rathana Kim, Florian Chevillon, Dario Ferrero, Marie Sébert, Nathalie Dhedin, Raphaël A Itzykson, Lionel Ades, Emmanuel Raffoux, Hervé Dombret, Ernesta Audisio, Emmanuelle Clappier, Nicolas Boissel
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. Blood advances 8 (10) (2024)
Giovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, Lambert Busque, Ester Pungolino, Elisabetta Abruzzese, Maria Cristina Miggiano, Chiara Elena, Alberto Álvarez-Larrán, Ana Triguero, Alessandra Iurlo, Cristina Bucelli, Marco Cerrano, Isabella Capodanno, Francesca Lunghi, Philipp le Coutre, Sara Galimberti, Giovanni Caocci, Margherita Maffioli, Fabio Stagno, Susanne Saussele, Rocco Giovanni Piazza, Brian J Druker, Carmen Fava, Veronica Guglielmana, Federica Colombo, Laura Antolini, Carlo B Gambacorti-Passerini
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study. American journal of hematology (2023)
Corrado Benevolo Savelli, Michele Clerico, Barbara Botto, Carolina Secreto, Federica Cavallo, Chiara Dellacasa, Alessandro Busca, Benedetto Bruno, Roberto Freilone, Marco Cerrano, Mattia Novo
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. Cancers 16 (1) (2023)
Nicola Stefano Fracchiolla, Alessandra Iurlo, Cristina Papayannidis, Antonella Vitale, Sabina Chiaretti, Mario Annunziata, Fabio Giglio, Prassede Salutari, Fabio Forghieri, Davide Lazzarotto, Monia Lunghi, Annalisa Imovilli, Barbara Scappini, Massimiliano Bonifacio, Michelina Dargenio, Carmela Gurrieri, Elisabetta Todisco, Marzia Defina, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Cerrano, Lidia Santoro, Elena Tagliaferri, Enrico Barozzi, Pasquale De Roberto, Marta Canzi, Elisa Buzzatti, Chiara Sartor, Francesco Passamonti, Robin Foà, Antonio Curti
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. Cancers 15 (18) (2023)
Chiara Frairia, Barbara Nicolino, Carolina Secreto, Emanuela Messa, Giulia Arrigo, Alessandro Busca, Marco Cerrano, Stefano D'Ardìa, Chiara Dellacasa, Andrea Evangelista, Roberto Freilone, Valentina Giai, Giorgio Priolo, Irene Urbino, Ernesta Audisio
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy. European journal of haematology (2023)
Vincenzo Apolito, Giulia Arrigo, Loic Vasseur, Matteo Olivi, Silvia Perrone, Valentina Giai, Carolina Secreto, Federica Di Biase, Maria Carla De Simone, Carolina Copia, Angela Gravetti, Roberto Freilone, Benedetto Bruno, Giuseppe Lanzarone, Eloise Beggiato, Chiara Frairia, Ernesta Audisio, Stefano D'Ardia, Dario Ferrero, Marco Cerrano, Felicetto Ferrara
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax. British journal of haematology (2023)
Eleonora Boscaro, Irene Urbino, Federica Maria Catania, Giulia Arrigo, Carolina Secreto, Matteo Olivi, Stefano D'Ardia, Chiara Frairia, Valentina Giai, Roberto Freilone, Dario Ferrero, Ernesta Audisio, Marco Cerrano
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. Cancers 15 (13) (2023)
Corrado Benevolo Savelli, Michele Clerico, Barbara Botto, Carolina Secreto, Federica Cavallo, Chiara Dellacasa, Alessandro Busca, Benedetto Bruno, Roberto Freilone, Marco Cerrano, Mattia Novo
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. Cancers 16 (1) (2023)
Michelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, Antonella Vitale, Nicola Stefano Fracchiolla, Cristina Papayannidis, Fabio Giglio, Prassede Salutari, Ernesta Audisio, Barbara Scappini, Patrizia Zappasodi, Marzia Defina, Fabio Forghieri, Anna Maria Scattolin, Elisabetta Todisco, Monia Lunghi, Fabio Guolo, Maria Ilaria Del Principe, Mario Annunziata, Davide Lazzarotto, Michele Cedrone, Crescenza Pasciolla, Annalisa Imovilli, Ilaria Tanasi, Silvia Trappolini, Marco Cerrano, Roberta La Starza, Mauro Krampera, Nicola Di Renzo, Anna Candoni, Giovanni Pizzolo, Felicetto Ferrara, Robin Foà
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study. British journal of haematology (2022)
Federica Martella, Marco Cerrano, Daniela Di Cuonzo, Carolina Secreto, Matteo Olivi, Vincenzo Apolito, Stefano D'Ardia, Chiara Frairia, Valentina Giai, Giuseppe Lanzarone, Irene Urbino, Roberto Freilone, Luisa Giaccone, Alessandro Busca, Chiara Maria Dellacasa, Ernesta Audisio, Dario Ferrero, Eloise Beggiato
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Annals of hematology 101 (4) (2022)
Silvia Arniani, Valentina Pierini, Fabrizia Pellanera, Caterina Matteucci, Danika Di Giacomo, Valentina Bardelli, Martina Quintini, Elena Mavridou, Anair Graciela Lema Fernandez, Carlotta Nardelli, Martina Moretti, Paolo Gorello, Barbara Crescenzi, Silvia Romoli, Donatella Beacci, Marco Cerrano, Nicola Fracchiolla, Simona Sica, Fabio Forghieri, Fabio Giglio, Michela Dargenio, Loredana Elia, Roberta La Starza, Cristina Mecucci
Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults. Leukemia 36 (11) (2022)
Luisa Giaccone, Lucia Brunello, Jaime Suarez Londono, Matilde Scaldaferri, Marco Cerrano, Valter Redoglia, Paola Omedè, Giuseppe Lia, Massimo Massaia, Dario Ferrero, Federica Cavallo, Sara Bringhen, Sarah Leone, Francesco Cattel, Tiziana Francisci, Valter Tassi, Andrea Evangelista, Mario Boccadoro, Benedetto Bruno
Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant. Bone marrow transplantation (2021)
Irene Urbino, Carolina Secreto, Matteo Olivi, Vincenzo Apolito, Stefano D'Ardia, Chiara Frairia, Valentina Giai, Semra Aydin, Roberto Freilone, Chiara Dellacasa, Luisa Giaccone, Dario Ferrero, Ernesta Audisio, Alessandro Busca, Marco Cerrano
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021. Cancers 13 (20) (2021)
Mikkael A Sekeres, Justin Watts, Atanas Radinoff, Montserrat Arnan Sangerman, Marco Cerrano, Patricia Font Lopez, Joshua F Zeidner, Maria Diez Campelo, Carlos Graux, Jane Liesveld, Dominik Selleslag, Nikolay Tzvetkov, Robert J Fram, Dan Zhao, Jill Bell, Sharon Friedlander, Douglas V Faller, Lionel Adès
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML. Leukemia 35 (7) (2021)
Fabio Guolo, Luana Fianchi, Paola Minetto, Marino Clavio, Michele Gottardi, Sara Galimberti, Giuliana Rizzuto, Michela Rondoni, Giambattista Bertani, Michela Dargenio, Atto Bilio, Barbara Scappini, Patrizia Zappasodi, Anna Maria Scattolin, Francesco Grimaldi, Giuseppe Pietrantuono, Pellegrino Musto, Marco Cerrano, Stefano D'Ardia, Ernesta Audisio, Alessandro Cignetti, Crescenza Pasciolla, Francesca Pavesi, Anna Candoni, Carmela Gurreri, Monica Morselli, Caterina Alati, Nicola Fracchiolla, Giovanni Rossi, Manuela Caizzi, Fabrizio Carnevale-Schianca, Agostino Tafuri, Giuseppe Rossi, Felicetto Ferrara, Livio Pagano, Roberto Massimo Lemoli
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program. Blood cancer journal 10 (10) (2020)
Luisa Giaccone, Francesco Felicetti, Sara Butera, Danilo Giuseppe Faraci, Marco Cerrano, Margherita Dionisi Vici, Lucia Brunello, Nicoletta Fortunati, Enrico Brignardello, Benedetto Bruno
Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach. Journal of blood medicine 11 (2020)
Matteo Dragani, Giovanna Rege Cambrin, Berchialla Paola, Irene Dogliotti, Gianantonio Rosti, Fausto Castagnetti, Isabella Capodanno, Bruno Martino, Marco Cerrano, Dario Ferrero, Carlo Gambacorti-Passerini, Monica Crugnola, Chiara Elena, Massimo Breccia, Alessandra Iurlo, Daniele Cattaneo, Sara Galimberti, Antonella Gozzini, Monica Bocchia, Francesca Lunghi, Michele Cedrone, Nicola Sgherza, Luigia Luciano, Sabina Russo, Marco Santoro, Valentina Giai, Giovanni Caocci, Luciano Levato, Elisabetta Abruzzese, Federica Sora, Giuseppe Saglio, Carmen Fava
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation. Journal of clinical medicine 9 (11) (2020)
Marco Cerrano, Matthieu Duchmann, Rathana Kim, Loic Vasseur, Pierre Hirsch, Xavier Thomas, Samuel Quentin, Justine Pasanisi, Marie Passet, Florence Rabian, Ramy Rahmé, Etienne Lengliné, Emmanuel Raffoux, Nathalie Dhédin, Marie Sébert, Odile Maarek, Anna Raimbault, Karine Celli-Lebras, Lionel Adès, Pierre Fenaux, Nicolas Boissel, François Delhommeau, Jean Soulier, Hervé Dombret, Emmanuelle Clappier, Pierre Sujobert, Raphaël A Itzykson
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy. Leukemia 35 (3) (2020)
Anna Candoni, Davide Lazzarotto, Felicetto Ferrara, Antonio Curti, Federico Lussana, Cristina Papayannidis, Maria Ilaria Del Principe, Massimiliano Bonifacio, Federico Mosna, Mario Delia, Paola Minetto, Michele Gottardi, Nicola Fracchiolla, Valentina Mancini, Fabio Forghieri, Patrizia Zappasodi, Marco Cerrano, Antonella Vitale, Ernesta Audisio, Silvia Trappolini, Claudio Romani, Marzia Defina, Silvia Imbergamo, Nadia Ciccone, Lidia Santoro, Benedetta Cambò, Salvatore Iaccarino, Michela Dargenio, Lara Aprile, Sabina Chiaretti, Renato Fanin, Giovanni Pizzolo, Roberto Foà
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study. American journal of hematology 95 (12) (2020)
Laura Cesini, Camilla Frieri, Claudia Baratè, Federica Sorà, Massimiliano Bonifacio, Marco Cerrano, Antonia Cagnetta, Chiara Elena, Lara Aprile, Nicola Sgherza, Malgorzata Trawinska, Antonella Gozzini, Isabella Capodanno, Monica Crugnola, Ida Carmosino, Emilia Scalzulli, Federica Ricci, Monica Bocchia, Micaela Bergamaschi, Chiara Aguzzi, Simona Sica, Sara Galimberti, Massimo Breccia, Luigiana Luciano, Roberto Latagliata
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia. European journal of haematology 105 (3) (2020)
Marco Cerrano, Barbara Castella, Giuseppe Lia, Matteo Olivi, Danilo G Faraci, Sara Butera, Federica Martella, Matilde Scaldaferri, Francesco Cattel, Mario Boccadoro, Massimo Massaia, Dario Ferrero, Benedetto Bruno, Luisa Giaccone
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia. British journal of haematology 191 (1) (2020)
Luisa Giaccone, Danilo Giuseppe Faraci, Sara Butera, Giuseppe Lia, Clara Di Vito, Giulia Gabrielli, Marco Cerrano, Jacopo Mariotti, Chiara Dellacasa, Francesco Felicetti, Enrico Brignardello, Domenico Mavilio, Benedetto Bruno
Biomarkers for acute and chronic graft versus host disease: state of the art. Expert review of hematology 14 (1) (2020)
Vincenzo Apolito, Luisa Giaccone, Simone Ferrero, Alessandra Larocca, Federica Cavallo, Marta Coscia, Eloise Beggiato, Sara Butera, Federica Martella, Cristina Dainese, Giusy Cetani, Matilde Scaldaferri, Francesco Cattel, Mario Boccadoro, Dario Ferrero, Benedetto Bruno, Marco Cerrano
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Annals of hematology 99 (9) (2020)
Enrico Maffini, Alessandro Busca, Cristina Costa, Luisa Giaccone, Marco Cerrano, Antonio Curtoni, Rossana Cavallo, Benedetto Bruno
An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Expert review of hematology 12 (11) (2019)
Marco Cerrano, Valérie Seegers, Emmanuel Raffoux, Florence Rabian, Marie Sébert, Raphael Itzykson, Virginie Lemiale, Lionel Adès, Nicolas Boissel, Hervé Dombret, Elie Azoulay, Etienne Lengliné
Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis. Leukemia & lymphoma 61 (3) (2019)
Marco Cerrano, Anna Candoni, Elena Crisà, Maria Vittoria Dubbini, Stefano D'Ardia, Maria Elena Zannier, Mario Boccadoro, Ernesta Audisio, Benedetto Bruno, Dario Ferrero
FLAI induction regimen in elderly patients with acute myeloid leukemia. Leukemia & lymphoma 60 (13) (2019)
Elena Crisà, Marco Cerrano, Eloise Beggiato, Giulia Benevolo, Giuseppe Lanzarone, Paola Maria Manzini, Alessandra Borchiellini, Ludovica Riera, Mario Boccadoro, Dario Ferrero
Can pegylated interferon improve the outcome of polycythemia vera patients? Journal of hematology & oncology 10 (1) (2017)

Marco Cerrano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Cerrano